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COVERAGE TIPS FOR PRINT AND BROADCAST MEDIA 
~ BIOLOGY PROFESSOR HELPS VICTIMS OF AIDS 
WITH DEVELOPMENT OF FDA-APPROVED 
atUD 
SICKNESS 
Brother Bruce Giffin, S.M., an assistant professor of biology at the 
University of Dayton, is one member of a team of researchers that worked to 
investigate a cure for African Sleeping Sickness. Along the way, the team 
discovered that the new drug they were researching (DFMO) also cures 
Pneumocystis pneumonia, a parasitic infection usually fatal to most AIDS 
patients. FDA approval to use the drug for treatment of the pneumonia came 
about a year ago. 
Prior to the final FDA approval, the drug was approved for "compassionate 
use" for AIDS victims who had gone through all other acceptable treatments. "It 
had real good results," Giffin said. "Now, with the FDA approval, it can be 
used before the infection has progressed to such an extreme stage." 
Merrill Dow Pharmaceuticals in Cincinnati is currently in full-scale 
production of the drug. The company, working through various government 
agencies and the World Health Organization, supplies the drug on request to 
physicians operating approved programs in Africa to combat the fatal African 
Sleeping Sickness in humans. "The drug has virtually no side effects," said 
Giffin. "Some of the African victims treated have gone several years without a 
relapse, so it looks good." 
For media interviews, contact Brother Bruce Giffin at (513) 229-2508. 
UD'S STRATEGIES FOR RESPONSIBLE DEVELOPMENT OFFICE 
ASSISTS NEIGHBORHOOD GROUPS WITH COMPUTERIZED ACCOUNTING SERVICE 
The days of keeping accounting records in an old shoe box may be over for 
several Dayton volunteer neighborhood associations. 
Thanks to a computerized accounting system developed by Brother Ed 
Zamierowski, S.M., through a grant from the United Way, groups such as the 
Edgemont Neighborhood Coalition, the Grow With Your Neighbor program and the 
Dayton View Community Development Corp. simply turn in their check stubs and 
deposit receipts each month to Zamierowski and a group of UD accounting majors, 
who generate monthly financial statements and develop cash-flow statements. 
"It's more than just keeping books," Zamierowski said. "It's helping 
neighborhood groups work out sound fiscal plans." 
Zamierowski is a program specialist in UD's Strategies for Responsible 
Development-Neighborhood Development Office. SRD sponsors training sessions, 
conferences and workshops that help neighborhood groups in their efforts to 
improve the quality of life in Dayton neighborhoods. 
For media interviews, contact Brothe1 Ed Zamierowski at (513) 229-4638. 
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For further information or assistance in scheduling interviews, contact Public Relations and University Communications, 229-3241. 
